Shorter Radiation Schedule for Hard-to-Treat Brain Tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new pattern of high-precision radiation (given over 3 days instead of 5) for people with a limited number of brain tumors from hard-to-treat cancers like melanoma or kidney cancer. The goal is to see if a shorter treatment schedule is just as effective and easier for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have between 1 and 5 brain tumors caused by a cancer type that is typically resistant to standard whole-brain radiation, like melanoma or kidney cancer.
- You are able to care for yourself (Karnofsky score over 50%).
- Your largest untreated brain tumor is smaller than 3.5 cm (about 1.4 inches).
- You have not had radiation therapy to the brain before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This trial tests giving targeted radiation while surgeons are operating to treat brain metastases. It may help control the cancer locally at the time of surgery, especially for certain single lesions.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This trial tests a new approach for people with a single large brain tumor that has spread from another cancer. You would receive a short, focused dose of radiation (stereotactic radiosurgery) in small, separate treatments, followed by surgery to remove the tumor. The goal is to see if this combination works better than the usual treatment.
This trial tests two different radiation margins (how much healthy tissue is included around a brain tumor) during a single treatment session. It aims to see which margin is better at controlling brain metastases while reducing side effects.
This trial compares the usual short course of radiation therapy (one session) to a longer course (up to 5 sessions) for people with cancer that has spread to the brain. The goal is to see if the longer course works better and causes fewer side effects.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.